Filters

Jagannadha K Sastry, Alexander Khalaf, Xiaowen Sun, Weihong Xiao, Peixin Jiang, Lacin Yapindi, Madison P O'Hara, Soma Ghosh, Maura L Gillison, Faye M Johnson, J Jack Lee, Hai T Tran, Alexandre Reuben

Clinical cancer research : an official journal of the American Association for Cancer Research 2025;31(3):479-490

Free Full Text

Abstract

Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.

Stacey Stein, Nilofer S Azad, Laura W Goff, Jennifer G Whisenant, Tatsuki Koyama, Ulka Vaishampayan, Howard Hochster, Roisin Connolly, Amy Weise, Patricia M LoRusso, Safia N Salaria, Wael El-Rifai, Jordan D Berlin

Investigational new drugs 2020;37(2):315-322

Free Full Text

Abstract

Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death.

Tewfik Hamidi, Carla E Cano, Daniel Grasso, Maria Noé Garcia, Maria José Sandi, Ezequiel L Calvo, Jean-Charles Dagorn, Gwen Lomberk, Raul Urrutia, Sandro Goruppi, Arkaitz Carracedo, Guillermo Velasco, Juan L Iovanna

Clinical cancer research : an official journal of the American Association for Cancer Research 2013;18(19):5234-46

Full Text

Abstract

Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.

Abhijit Mazumdar, Ying C Henderson, Adel K El-Naggar, Subrata Sen, Gary L Clayman

Head & neck 2009;31(5):625-34

Free Full Text

Abstract

BAG3 is a negative regulator of ciliogenesis in glioblastoma and triple-negative breast cancer cells.

Benedikt Linder, Caterina Klein, Marina E Hoffmann, Florian Bonn, Ivan Dikic, Donat Kögel

Journal of cellular biochemistry 2022;123(1):77-90

Full Text

Abstract

Switching Aurora-A kinase on and off at an allosteric site.

Selena G Burgess, Patrick J McIntyre, Richard Bayliss

The FEBS journal 2017;284(18):2947-2954

Free Full Text

Abstract

Results: 1 – 14 / 14

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Aurora Kinase A""[mesh_terms]

PD-L1 and the Clinical Outcomes of Ovarian Cancer: Meta-Analysis and Bioinformatical Analysis.

Ubiquitination site preferences in anaphase promoting complex/cyclosome (APC/C) substrates.

Understanding the Differences of Danusertib's Residence Time in Aurora Kinases A/B: Dissociation Paths and Key Residues Identified using Conventional and Enhanced Molecular Dynamics Simulations.

Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.

Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.

A moving target: structure and disorder in pursuit of Myc inhibitors.

Resveratrol inhibits bladder cancer proliferation by targeting the AURKA/STAT3 axis: From computational analysis to experimental validation.

Inhibition of the Hedgehog signaling pathway suppresses cell proliferation by regulating the Gli2/miR-124/AURKA axis in human glioma cells.

Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas.

Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.

Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death.

Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.

BAG3 is a negative regulator of ciliogenesis in glioblastoma and triple-negative breast cancer cells.

Switching Aurora-A kinase on and off at an allosteric site.

Results for
""Aurora Kinase A""[mesh_terms]